GNRH1 and polycystic ovary syndrome: Thus, whether the GnRH antagonist protocol leads to lower severe OHSS rates compared to the GnRH agonist protocol in PCOS patients with lower AMH and lower bLH/FSH levels is a point of confusion that has not been investigated by previous studies.